ConductScience.org, home

Paper8775802

Correlation between viral load measurements and outcome in clinical trials of antiviral drugs.

Schooley RT. AIDS, 1995. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. Correlation between viral load measurements and outcome in clinical trials of antiviral drugs. Papers, record 8775802. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8775802

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Correlation between viral load measurements and outcome in clinical trials of antiviral drugs.
PubMed
Journal
AIDS
PubMed
Year
1995
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
0.77
iCite
Revised in PubMed
2013-05-20
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Schooley RTR T

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Clinical Trials as TopicMajor topic
HIV InfectionsMajor topic
Humans
Treatment Outcome

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT00000671A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine TreatmentBackgroundClinicalTrials.gov
NCT00000979Comparison of ddI Versus Zidovudine in HIV-Infected PatientsBackgroundClinicalTrials.gov

Download CSV of trials

Cited by12

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
36131274Correlating drug prescriptions with prognosis in severe COVID-19: first step towards resource management.BMC Med Inform Decis Mak2022https://conductscience.org/library/papers/36131274PubMed
21084515
Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.
J Clin Microbiol2011https://conductscience.org/library/papers/21084515PubMed
21067547Models of RNA virus evolution and their roles in vaccine design.Immunome Res2010https://conductscience.org/library/papers/21067547PubMed
20477714Biomarkers of HIV-1-associated neurocognitive disorders: challenges of proteomic approaches.Biomark Med2009https://conductscience.org/library/papers/20477714PubMed
12707851Human immunodeficiency virus-associated dementia: an evolving disease.J Neurovirol2003https://conductscience.org/library/papers/12707851PubMed
11880441Ratio of two successive optical densities from the Roche HIV-1 monitor test as a measure of accuracy of estimates of human immunodeficiency virus RNA concentration.J Clin Microbiol2002https://conductscience.org/library/papers/11880441PubMed
10698998Simultaneous detection of multiplex-amplified human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA using a flow cytometer microsphere-based hybridization assay.J Clin Microbiol2000https://conductscience.org/library/papers/10698998PubMed
10681212Obtaining unacceptable results in assays for quantitation of human immunodeficiency virus type 1 RNA in plasma samples.J Clin Microbiol2000https://conductscience.org/library/papers/10681212PubMed
10225838Comparison of the frequencies and levels of human immunodeficiency virus type 1 markers in specimens from chronically infected human T-lymphocyte cultures and from patients.Clin Diagn Lab Immunol1999https://conductscience.org/library/papers/10225838PubMed
10074556Comparison of levels of human immunodeficiency virus type 1 RNA in plasma as measured by the NucliSens nucleic acid sequence-based amplification and Quantiplex branched-DNA assays.J Clin Microbiol1999https://conductscience.org/library/papers/10074556PubMed
9508301Clinical comparison of an enhanced-sensitivity branched-DNA assay and reverse transcription-PCR for quantitation of human immunodeficiency virus type 1 RNA in plasma.J Clin Microbiol1998https://conductscience.org/library/papers/9508301PubMed
9472655Early increase of CD4+ CD45RA+ and CD4+ CD95- cells with conserved repertoire induced by anti-retroviral therapy in HIV-infected patients.Clin Exp Immunol1998https://conductscience.org/library/papers/9472655PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8775802

GET https://conductscience.org/api/papers/v1/8775802/authors